Download PDF
Thorac Cardiovasc Surg 2004; 52(6): 344-348
DOI: 10.1055/s-2004-830323
Original Cardiovascular

© Georg Thieme Verlag KG Stuttgart · New York

Extended Myectomy for Hypertrophic Obstructive Cardiomyopathy after Failure or Contraindication of Septal Ablation or with Combined Surgical Procedures[*]

H. Dörge1 , J. D. Schmitto1 , O. J. Liakopoulos1 , S. Walther1 , F. A. Schöndube1
  • 1Thoracic Cardiovascular Surgery, Heart Center Göttingen, Georg-August University Göttingen, Göttingen, Germany
Further Information

Publication History

Received April 15, 2004

Publication Date:
01 December 2004 (online)

    Permissions and Reprints All articles of this category

Abstract

Background: Surgical correction of hypertrophic obstructive cardiomyopathy in severely symptomatic patients has been proven to be effective over the long term. The introduction of catheter-based procedures restricts surgical therapy to a subset of patients not suitable for septal ablation or requiring concomitant cardiac surgery. Methods: Between 8/2001 and 8/2003, 25 patients (58 ± 15 years) underwent extended transaortic septal myectomy with partial excision and mobilization of the papillary muscles. Concomitant surgical procedures were performed in 40 % (CABG n = 9, aortic valve replacement n = 2). In 24 %, prior septal ablation was ineffective. Intraventricular gradient was 80 ± 29 mm Hg at rest and 143 ± 35 mm Hg during exercise. Mitral regurgitation affected 72 % of patients, and 88 % were NYHA functional class III or IV. Results: No hospital death, no postsurgical ventricular septal defect, and no complete atrioventricular block occurred. Severe nonfatal complications occurred in 24 % of patients. Intensive care was necessary for 1.8 ± 1.7 days; total hospital stay was 11.8 ± 3.8 days. Early follow-up was complete in 100 % (15 ± 6 months, total of 376 months) with no late deaths, no relevant mitral regurgitation, or intraventricular gradients. Functional status was markedly improved (NYHA class I 40 %, class II 56 %, class III 4 %). Conclusions: Early results of extended surgical myectomy and reconstruction of the subvalvular mitral apparatus in hypertrophic obstructive cardiomyopathy remain excellent with respect to mortality, morbidity, and functional capacity even when restricting surgery to patients earlier supposed to be at high risk.

Key words

Hypertrophic cardiomyopathy - myectomy - cardiac surgery

1 Presented at the 4th annual meeting of the German, Austrian, and Swiss Society for Thoracic and Cardiovascular Surgery, February 15 - 18, 2004 in Hamburg, Germany

References

  • 1 Morrow A G, Reitz B A, Epstein S E. et al . Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients.  Circulation. 1975;  52 88-102
    PubMedGoogle Scholar
  • 2 Maron B J, McKenna W J, Danielson G K. et al . American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.  J Am Coll Cardiol. 2003;  42 1687-1713
    CrossrefPubMedGoogle Scholar
  • 3 Schulte H D, Borisov K, Gams E, Gramsch-Zabel H, Losse B, Schwartzkopff B. Management of symptomatic hypertrophic obstructive cardiomyopathy long-term results after surgical therapy.  Thorac Cardiovasc Surg. 1999;  47 213-218
    PubMedGoogle Scholar
  • 4 Schöndube F A, Klues H G, Reith S, Flachskampf F A, Hanrath P, Messmer B J. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus.  Circulation. 1995;  92 II122-II127
    PubMedGoogle Scholar
  • 5 ten Berg J M, Suttorp M J, Knaepen P J, Ernst S M, Vermeulen F E, Jaarsma W. Hypertrophic obstructive cardiomyopathy. Initial results and long-term follow-up after Morrow septal myectomy.  Circulation. 1994;  90 1781-1785
    PubMedGoogle Scholar
  • 6 Mohr R, Schaff H V, Danielson G K, Puga F J, Pluth J R, Tajik A J. The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy - Experience over 15 years.  J Thorac Cardiovasc Surg. 1989;  97 666-674
    PubMedGoogle Scholar
  • 7 Heric B, Lytle B W, Miller D P, Rosenkranz E R, Lever H M, Cosgrove D M. Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results.  J Thorac Cardiovasc Surg. 1995;  110 195-206
    CrossrefPubMedGoogle Scholar
  • 8 Williams W G, Wigle E D, Rakowski H, Smallhorn J, Leblanc J, Trusler G A. Results of surgery for hypertrophic obstructive cardiomyopathy.  Circulation. 1987;  76 104-108
    PubMedGoogle Scholar
  • 9 Robbins R C, Stinson E B. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy.  J Thorac Cardiovasc Surg. 1996;  111 586-593
    PubMedGoogle Scholar
  • 10 Cohn L H, Trehan H, Collins J J. Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy.  Am J Cardiol. 1992;  70 657-660
    CrossrefPubMedGoogle Scholar
  • 11 Krajcer Z, Leachman R D, Cooley D A, Coronado R. Septal myotomy-myomectomy versus mitral valve replacement in hypertrophic cardiomyopathy. Ten-year follow-up in 185 patients.  Circulation. 1989;  80 I57-I64
    PubMedGoogle Scholar
  • 12 Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.  Lancet. 1995;  346 211-214
    CrossrefPubMedGoogle Scholar
  • 13 Kuhn H, Gietzen F, Leuner C, Gerenkamp T. Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment.  Eur Heart J. 1997;  18 846-851
    CrossrefPubMedGoogle Scholar
  • 14 Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt H K, Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.  J Am Coll Cardiol. 1998;  31 252-258
    PubMedGoogle Scholar
  • 15 Maron B J. Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy.  Lancet. 2000;  355 425-426
    PubMedGoogle Scholar
  • 16 Siegman I L, Maron B J, Permut L C, Mcintosh C L, Clark R E. Results of operation for coexistent obstructive hypertrophic cardiomyopathy and coronary-artery disease.  J Am Coll Cardiol. 1989;  13 1527-1533
    PubMedGoogle Scholar
  • 17 Messmer B J. Extended myectomy for hypertrophic obstructive cardiomyopathy.  Ann Thorac Surg. 1994;  58 575-577
    CrossrefPubMedGoogle Scholar
  • 18 Schöndube F A, Klues H G, Reith S, Messmer B J. Surgical correction of hypertrophic obstructive cardiomyopathy with combined myectomy, mobilisation and partial excision of the papillary muscles.  Eur J Cardiothorac Surg. 1994;  8 603-608
    CrossrefPubMedGoogle Scholar
  • 19 Klues H G, Schiffers A, Maron B J. Phenotypic spectrum and patterns of left-ventricular hypertrophy in hypertrophic cardiomyopathy - Morphologic observations and significance as assessed by 2-dimensional echocardiography in 600 patients.  J Am Coll Cardiol. 1995;  26 1699-1708
    CrossrefPubMedGoogle Scholar
  • 20 Maron M S, Olivotto I, Betocchi S. et al . Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.  N Engl J Med. 2003;  348 295-303
    CrossrefPubMedGoogle Scholar

1 Presented at the 4th annual meeting of the German, Austrian, and Swiss Society for Thoracic and Cardiovascular Surgery, February 15 - 18, 2004 in Hamburg, Germany

Dr. Hilmar Dörge

Thorax-, Herz- und Gefäßchirurgie, Herzzentrum Göttingen, Georg-August-Universität Göttingen

Robert-Koch-Straße 40

37075 Göttingen

Germany

Phone: + 49551396006

Fax: + 49 5 51 39 60 02

Email: doerge@med.uni-goettingen.de

      >